ANI Pharmaceuticals | ANIP - Capital Ordinário





Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 58.95M 2.24M 2026-03
Canopy Growth CAD 422.07M 53.78M 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
Emergent BioSolutions USD 100K 0 2023-06
Heron Therapeutics USD 188.31M 4.99M 2025-12
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Novartis USD 1.91B 60K 2026-03
Omeros USD 611K 17K 2023-12
Perrigo USD 138.1M 500K 2026-03
Sun Pharmaceuticals INR 2.4B 0 2026-03
Teva Pharmaceutical Industries USD 1.16B 1000K 2026-06